Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

DEFECTIVE DRUGS ARCHIVES

Defective Drug Lawsuit Archives Page

The following is a listing of past defective drug lawsuits and articles that Parker Waichman LLP, a leading personal injury law firm has defended for our clients or been instrumental in getting these drugs recalled. Our experienced defective drug attorneys will continually evaluate these cases involving defective drug lawsuits throughout the United States.

Drugs with deadly or dangerous side effects often make it to the market because their potential dangers were not anticipated during clinical trials. These defective drugs have been classified and identified by the FDA as having dangerous side effects that outweigh whatever benefits they may have.

Such an FDA classification often leads to drug recalls, personal injuries and lawsuits against drug companies.

To view more information involving a specific defective drug, drug recall, or drug lawsuits, please click on one of the links listed below. Visit our active Defective Drugs lawsuit page if you do not see the drug  listed on this page if you would like more information.

If you seek an experienced defective drug lawyer, please fill out the form at the right for a free case evaluation by one of our qualified attorneys.

Tags:  

Defective Drugs Archives NewsRSS Feed

Kentucky Lawsuit over OxyContin could be Detrimental to Manufacturer

Oct 24, 2014
The state of Kentucky has filed a lawsuit over the best-selling painkiller OxyContin that could be devastating for manufacturer Purdue. According to...

Bausch & Lomb Owner Seeks IPO after Private Sale Fails

Feb 25, 2013
The company that overtook pharmaceutical firm Bausch & Lomb in 2007 is now pitching the idea of an Initial Public Offering to the nation’s...

Swedish Woman Dies after six Tysabri Infusion Treatments for Multiple Sclerosis

Feb 13, 2013
Physicians in Sweden have reported that a multiple sclerosis patient they were treating with the drug Tysabri has died.According to a...

Acetaminophen Overdose A Risk For Infants, Children

Jun 7, 2012 | Parker Waichman LLP
Acetaminophen overdose, long known to be a risk for adults, is a risk for infants, as well. Acetaminophen is the active ingredient in Tylenol and,...

No Conclusion From FDA on Possible SSRI Antidepressant, PPHN Link

Dec 14, 2011 | Parker Waichman LLP
The U.S. Food & Drug Administration (FDA) still can't answer the question of whether taking selective serotonin reuptake inhibitor (SSRI)...
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo